Download - Type 1 diabetes self-management: a patient's experience of using CGMS

Transcript

Original ArticleBarriers to evidence-based practice integration

EDN Spring 2010 Vol.7 No.1 Copyright © 2010 FEND. Published by John Wiley & Sons 15

Evid Based Nurs 2006; 9: 38–40.2. Dijkstra RF, Braspenning JCC,

Huijsmans Z, et al. Patients andnurses determine variation in adher-ence to guidelines at Dutch hospitalsmore than internists or settings.Diabetic Med 2004; 21: 586–591.

3. Grol R, Grimshaw J. From best evidence to best practice: effectiveimplementation of change in patients’care. Lancet 2003; 3: 1225–1230.

4. Caldwell K, Coleman K, Copp G, et al.Preparing for professional practice:How well does professional trainingequip health and social care practition-ers to engage in evidence-based prac-tice? Nurse Edu Today 2007; 27: 518–528.

5. Flores-Mateo G, Argimon JM. Evidencebased practice in postgraduate health-care education: a systematic review.BMC Health Services Research 2007; 7: 119.

6. Del Mar C, Glasziou P, Mayer D.Teaching evidence based medicine.

BMJ 2004; 329: 989–990. 7. Coomarasamy A, Khan KS. What is

the evidence that postgraduate teach-ing in evidence-based medicinechanges anything? A systematicreview. BMJ 2004; 329: 1017.

8. Straus SE, Richardson WS, Glasziou P,et al. Evidence-based medicine: how topractice and teach EBM. 3rd Ed.Edinburgh: Elsevier ChurchillLivingstone, 2005.

9. Carley, K. Content analysis. In: AsherRE (ed) The Encyclopedia ofLanguage and Linguistics. Edinburgh:Pergamon Press, 1990.

10. Jante Law. http://en.wikipedia.org/wiki/Jante_Law. Accessed 06 January2010.

11. Mckenna HP, Ahton S, Keeney S.Barriers to evidence-based practice inprimary care. J Adv Nurs 2004; 45:178–189.

12. Gerrish K, Clayton J. Promoting

evidence-based practice: an organiza-tional approach. J Nurs Management2004; 12: 114–123.

13. Van Achterberg T, Schoonhoven, GrolR. Nursing implementation science:How evidence-based nursing requiresevidence-based implementation. JNurs Scholarship 2008; 40: 302–310.

14. Meijers JMM, Janssen MAP,Cummings GG, et al. Assessing therelationships between contextualfactors and research utilization innursing: systematic literature review.J Adv Nurs 2006; 55: 622–635.

15. Wallin L, Ewald U, Wikblad K, et al.Understanding work contextual factors:A short-cut to evidence-based practice?Worldviews on Evidence-based Nursing2006; 3: 153–164.

16. Shaneyfelt T, Baum KD, Bell D, et al.Instruments for evaluating educationin evidence-based practice. A systematicreview. JAMA 2006; 296: 1116–1127.

Sir, I have had brittle type 1 diabetes for 32 years from the ageof 10, developing cataracts andperipheral neuropathy at 13 years,and autonomic neuropathy andsevere gastroparesis aged 20 causing difficulty in matching myinsulin needs to the rate of diges-tion. In 2000 I gained funding forinsulin pump therapy, allowing meto moderate my basal and bolusinsulin requirements accordingly.My complications have stabilisedand my average HbA1c is always6–7%. I do not have a pump-trained diabetes consultant.

In April 2009 I asked my PCT tofund a CGMS, stating the reasonswhy I have a clinical need for thistreatment, emphasising my frequenthypoglycaemia with no warningsigns. I pointed out that a systemthat could warn me of my blood glucose trends would be of immensebenefit to my quality of life. I alsoprovided the annual CGMS fundingcosts. In May 2009 my PCT agreedongoing funding of an insulin pumpwith integral CGMS.

The CGMS is calibrated 3–4times a day with SMBG levels foroptimal results. I insert the sensorsubcutaneously into my abdomenand it reads interstitial glucose levels every 10 minutes. This signalis transmitted to the pump’s software, forming a graph dis-played on the pump screen. I set my desired glucose limits at4–10mmol/L to gain tighter con-trol with gastroparesis, resulting infrequent alarms as the pump alertsme of predicted glucose trends. Ihave opted to silence the noctur-nal expected high alarms becauseof disturbed sleep.

Many of the alarms are predicted post-prandial highsallowing me to fine-tune my bolusand basal insulin requirementsafter meals. I soon realised that tissue and blood glucose levels aredissimilar. When comparing theaccuracy of a typical six-day (144hours) sensor life, only half of mypaired sensor and blood glucosereadings are the same or within0.5mmol/L, but at least five

readings show a difference of9mmol/L or more.

It is difficult to maintain normoglycaemia without theincreased risk of hypoglycaemia as diabetes control is tightened.However the benefits of using thissystem far outweigh any disadvan-tages in replacing my absent hypo-glycaemia warning signs, allowingme to take remedial action andgiving peace of mind. It has alsoenabled improved glycaemic control which will help slow theprogression of current and futurecomplications of diabetes. I wouldrecommend the CGMS to anyonewishing to effectively self-managetheir diabetes.

Dr Valerie Wilson, Head ofResearch, The Insulin PumpTherapy (INPUT) national volun-tary diabetes organisation, UK, e-mail: [email protected] Diabetes Nursing welcomes letters on any subject.Letters can be emailed to:[email protected]

Type 1 diabetes self-management: a patient’s experience of using CGMS